Chronic Kidney Disease

@ckd_ce on Twitter


Faculty                                  Relationship Identified With:
Hans-Joachim Anders, M.D.Consultant: Bayer, AstraZeneca, GSK, Novartis, Janssen; Speaker Honorarium: Lilly, Vifor, Otsuka
Sophia AmbrusoConsultant: AstraZeneca
Christos Argyropoulos MD, PhD, FASNConsultant: Baxter Healthcare, Bayer
Roopen AryaSpeaker’s Bureau: Sanofi, Cardinal Health
Jonathan BarrattResearch Grants: Argenx, Calliditas Therapeutics, Chinook Therapeutics, Galapagos NV, GSK, Novartis, Travere Therapeutics; Medical/Scientific Advisor: Alnylam Pharmaceuticals, Argenx, Astellas Pharma, BioCryst Pharmaceuticals, Calliditas Therapeutics, Chinook Therapeutics, Dimerix, Galapagos NV, Novartis, Omeros, Travere Therapeutics, UCB, Vera Therapeutics, Visterra
Sheila Bermejo GarcíaReports honorarium for conferences, consulting fees, and advisory boards from AstraZeneca, Boehringer and Mundipharma
Snehal H. Bhatt, PharmDSpeaker’s Bureau: Janssen Global Services, LLC
Hannah BebaConsultant and Speaker: AstraZeneca, Sanofi, Novonordisk; Sponsorship for Conference and Consultant and Speaker: BI/Lilly
Clara García CarroTravel and congress fees support from AstraZeneca, Esteve, NovoNordisk, Boehringer Ingelheim Lilly, Astellas, Otsuka, Novartis, Astellas, and Baxter; Scientific lectures, advisory boards and scientific committees organized by AstraZeneca, Boehringer Ingelheim Lilly, Mundipharma, Esteve and NovoNordisk
Melvin Chan MDNothing to disclose
Dr. Fouad T. ChebibUnrestricted research grant: Otsuka Pharmaceuticals; PI of ongoing clinical study: Natera
Daniel W. CoyneConsultant: Otsuka/Akebia, Boehringer/Lilly, FMC-Renal Therapies Group, Travere, Unicycive, Daicho Sankyo; Speaker: Astra Zeneca Canada; Consultant, Speaker: Fresenius Kabi.
Claire DaviesSpeaker: NovoNordisk, CMM, Astra Zeneca, CareFlow Medicines Management, Diabetes Professional Care, NAPP; Advisor: MTech Access, Roche; Author: Green Light Pharmacy
Tejas DesaiNothing to disclose
Kevin Fernando, MD  Consultant/Advisor: AstraZeneca Pharmaceuticals; Bayer AG; Boehringer Ingelheim International GmbH; Bristol Myers Squibb; Eli Lilly and Company; MSD Pharmaceuticals; NAPP Pharmaceuticals Limited; Novo Nordisk A/S; Sanofi Speaker’s Bureau: AstraZeneca Pharmaceuticals; Bayer AG; Boehringer Ingelheim International GmbH; Bristol Myers Squibb; Eli Lilly and Company; MSD Pharmaceuticals; NAPP Pharmaceuticals Limited; Novo Nordisk A/S; Sanofi; Daiichi Sankyo, Amgen & Amarin
Ines FonsecaSpeaker, conference support: Novo Nordisk; Conference support: Lilly; Speaker: AstraZeneca
Dominique Guerrot, MD, PhDNothing to disclose
Dr. Ilana HalperinSpeaker, Consultant: Dexcom Canada, Sanofi; Speaker: Sanofi; Consultant: Abbott Diabetes Canada
Tess HarrisNothing to disclose
Gerren Hobby, MDNothing to disclose
Will Herrington, MA, MBBS, MD, FRCPPersonal fellowship and institutional grant funding: Medical Research UK and Kidney Research UK.
Research support: Boehringer Ingelheim and Lilly.
I follow a departmental policy to decline any honoraria from the pharmaceutical or food industry.
Dr. Patrick Holmes MB BS, MSc, DipTher, MRCGPConsultant: AstraZeneca, NovoNordisk, Eli Lilly, Abbot; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim, NovoNordisk, Eli Lilly; Research Grant Recipient: NovoNordisk, Roche
Noah Ivers, MD, CCFP, PhDEvaluation consulting and speakers fee: Novo Nordisk; Evaluation consulting: Merck
Ellie Kelepouris MDAdvisor: Akebia Pharmaceuticals, Boehringer Ingleheim, Relypsa, GSK; Advisor/Author: Bayer Pharmaceuticals; Author/Section Editor: Up to Date; Advisor/Presenter: AstraZeneca.
Edgar V. LermaSpeaker’s Bureau: AstraZeneca; Bayer; Otsuka
Consultant: Vifor; Otsuka; Bayer
Hector MadariagaNothing to disclose
Ahmad MasriResearch Grants: Pfizer, Akcea, Ionis, Ultromics; Honoraria: Pfizer, Alnylam, Eidos, Akcea, Ionis, Cytokinetics, BMS; Consultant: Attralus, Tenaya, Ionis
Taher Modarressi, MDSpeakers’ Bureau: AstraZeneca
Dr Ahmed Mohsen, MD, MSc.Nothing to disclose
James Novak, MD PhD FASN FNKF FACP Nothing to disclose
Ali W. RizviNothing to disclose
Augusto Cesar Soares dos Santos JuniorNothing to disclose
Naveed SattarConsulting/speaker honoraria: Abbott Laboratories, Afimmune, Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Hanmi Pharmaceuticals, Janssen, MSD, Novartis, Novo Nordisk, Pfizer, Roche Diagnostics, Sanofi; Grants: AstraZeneca, Boehringer Ingelheim, Novartis, Roche Diagnostics 
Dr Mythri ShankarNothing to disclose
Dr Sourabh SharmaNothing to disclose
Natalie Staplin, PhDResearch funding paid to institution for EMPA-KIDNEY trial: Boehringer Ingleheim; Eli Lilly and Company. Research funding paid to institution ASCEND-PLUS trial: Novo Nordisk.
Dr. M. SubashriNothing to disclose
Cristina PopaNothing to disclose
Pallavi PrasadNothing to disclose
Robert Provenzano, MD, FACP, FASN, FNKFConsultant: Fibrogen, GSK; BOD/Stock: Nephroceuticals, Organic Arthritis, Vasc-Alert
Dr. Amar PuttannaSpeaker’s Bureau: Novo Nordisk, Lilly-Boehringer Ingelheim, Sanofi, Daiichi- Sankyo, AstraZeneca; Consulting: Sanofi
Sai Santhoshini Achi, MDNothing to disclose
Abdul Qader MDNothing to disclose
Catherine QuinlanNothing to disclose
Richard PratleyGrants from Hanmi Pharmaceutical Co., Janssen; Consulting, Speak Fees from Merck; Grants, Speaker Fees and Consulting Fees from Novo Nordisk; Consulting Fees from Pfizer; Grants from Poxel SA; Grants and Consulting Fees from Sanofi; Consulting Fees From Scohia Pharma Inc.; Consulting Fees From Sun Pharmaceutical Industries (All honoraria directed toward a non-profit which supports education and research.)
Brian Rifkin, MDNothing to disclose
Jade Teakell, MDNothing to disclose
Carlo Nemesio Trinidad, MD, FPCP, FPSNSpeaker: AstraZeneca; Corbridge Philippines; Otsuka; Sanofi
Didem Turgut MD, MScNothing to disclose
Dilushi WijayaratneNothing to disclose

All relevant financial relationships with ineligible companies for this educational content have been mitigated.